SPRINGWORKS THERAPEUTICS, INC.

(SWTX)
  Rapport
Temps Différé Nasdaq  -  20/05 22:00:00
37.19 USD   +5.00%
05/05SpringWorks Therapeutics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2022
CI
01/03SPRINGWORKS THERAPEUTICS, INC. : HC Wainwright favorable sur le dossier
ZM
24/02SpringWorks Therapeutics, Inc. annonce ses résultats pour l'année complète se terminant le 31 décembre 2021.
CI
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur SPRINGWORKS THERAPEUTICS, INC.
20/05SPRINGWORKS THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form..
16/05SpringWorks Therapeutics to Host Virtual R&D Day on June 10, 2022
16/05SpringWorks Therapeutics to Host Virtual R&D Day on June 10, 2022
05/05SPRINGWORKS THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condi..
05/05SPRINGWORKS THERAPEUTICS : Q1 Earnings Snapshot
05/05SpringWorks Therapeutics Reports First Quarter 2022 Financial Results and Recent Busine..
05/05SpringWorks Therapeutics Reports First Quarter 2022 Financial Results and Recent Busine..
05/05SpringWorks Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended Mar..
19/04SpringWorks Therapeutics, Regeneron Collaborate to Test Multiple Myeloma Combination Th..
19/04SpringWorks Therapeutics Announces Clinical Trial Collaboration and Supply Agreement wi..
16/03TRANSCRIPT : SpringWorks Therapeutics, Inc. Presents at Barclays Global Healthcare Confere..
24/02SPRINGWORKS THERAPEUTICS : Q4 Earnings Snapshot
24/02SPRINGWORKS THERAPEUTICS : Reports Fourth Quarter and Full-Year 2021 Financial Results and..
24/02SPRINGWORKS THERAPEUTICS, INC. Management's discussion and analysis of financial condi..
24/02SpringWorks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended Decembe..
24/02SpringWorks Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results an..
01/02SpringWorks Therapeutics to Present at Upcoming Investor Conferences
11/01TRANSCRIPT : SpringWorks Therapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Co..
04/01SpringWorks Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conferenc..
2021SpringWorks Therapeutics, AbbVie to Collaborate on Myeloma Combo Therapy Study
2021SpringWorks Therapeutics Announces Clinical Collaboration with AbbVie to Evaluate Nirog..
2021SpringWorks Therapeutics Announces Dosing of First Patient in Phase 1b/2 Trial Evaluati..
2021Springworks Therapeutics, Inc. Announces Dosing of First Patient in Phase 1B/2 Trial Ev..
2021SpringWorks Therapeutics Completes Enrollment in Trial of Mirdametinib in NF1-Associate..
2021SpringWorks Therapeutics Announces Full Enrollment of Phase 2b ReNeu Trial Evaluating M..
2021Springworks Therapeutics Announces Full Enrollment of Phase 2B ReNeu Trial Evaluating M..
2021SpringWorks Therapeutics to Participate in the 4th Annual Evercore ISI HealthCONx Confe..
2021SpringWorks Therapeutics Corporate Presentation
2021SPRINGWORKS THERAPEUTICS : Q3 Earnings Snapshot
2021SpringWorks Therapeutics Reports Third Quarter 2021 Financial Results and Recent Busine..
2021SPRINGWORKS THERAPEUTICS, INC. : Results of Operations and Financial Condition (form 8-K)
2021SPRINGWORKS THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condi..
2021SpringWorks Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine ..
2021SpringWorks Therapeutics Reports Third Quarter 2021 Financial Results and Recent Busine..
2021SpringWorks Therapeutics Announces the Initiation of an Expanded Phase 2 Cohort and Add..
2021SPRINGWORKS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other Events,..
2021SpringWorks Therapeutics Announces the Initiation of an Expanded Phase 2 Cohort and Add..
2021SpringWorks Therapeutics Announces the Initiation of an Expanded Phase 2 Cohort and Add..
2021INSIDER SELL : Springworks Therapeutics
2021SPRINGWORKS THERAPEUTICS : Working With Ab Magnitude on Next-Generation Oncology Therapeut..
2021SPRINGWORKS THERAPEUTICS : to Collaborate with Ab Magnitude on Target Identification and D..
2021SpringWorks Therapeutics, Inc. to Collaborate with Ab Magnitude Ventures Group, LLC and..
2021SPRINGWORKS THERAPEUTICS : to Collaborate with Leading Academic Institutions to Advance Po..
2021SpringWorks Therapeutics, Inc. to Collaborate with Dana-Farber Cancer Institute and Sta..
2021SPRINGWORKS THERAPEUTICS : Submission of Matters to a Vote of Security Holders (form 8-K/A..
2021SPRINGWORKS THERAPEUTICS : to Present at the H.C. Wainwright 23rd Annual Global Investment..
2021SPRINGWORKS THERAPEUTICS : Enters into Research Collaboration with Leading Cancer Institut..
2021Springworks Therapeutics Enters into Research Collaboration with Leading Cancer Institu..
2021SPRINGWORKS THERAPEUTICS : Corporate Presentation`
2021SPRINGWORKS THERAPEUTICS : Strengthened Leadership Team with Appointments of Dr. Mike Burg..
2021SPRINGWORKS THERAPEUTICS, INC. : Results of Operations and Financial Condition (form 8-K)
2021SPRINGWORKS THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and..
2021SPRINGWORKS THERAPEUTICS : Q2 Earnings Snapshot
2021SpringWorks Therapeutics Reports Second Quarter 2021 Financial Results and Recent Busin..
2021SpringWorks Therapeutics, Inc. Announces Unaudited Consolidated Earnings Results for th..
2021SPRINGWORKS THERAPEUTICS : to Present at the 12th Annual Wedbush PacGrow Healthcare Confer..
2021SPRINGWORKS THERAPEUTICS : Announces Phase 1b/2a Clinical Trial of Mirdametinib in Patient..
2021SpringWorks Therapeutics Announces Phase 1b/2a Clinical Trial of Mirdametinib in Patien..
2021SPRINGWORKS THERAPEUTICS : Appoints Dr. James Cassidy as Chief Medical Officer
2021SpringWorks Therapeutics, Inc. Appoints James Cassidy as Chief Medical Officer
2021SPRINGWORKS THERAPEUTICS : Receives US Composition of Matter Patent to Polymorphic Form of..
2021SPRINGWORKS THERAPEUTICS : Announces Issuance of New U.S. Composition of Matter Patent to ..
2021SECTOR UPDATE : Health Care Stocks Mixed Premarket Monday
2021PRECISION BIOSCIENCES : Doses First Patient in Study Evaluating Combination Drug Therapy A..
2021SPRINGWORKS THERAPEUTICS : Precision BioSciences and SpringWorks Therapeutics Dose First P..
2021SPRINGWORKS THERAPEUTICS : Launches Phase 1/2 Trial of Potential Low-Grade Glioma Drug
2021SpringWorks Therapeutics Announces Initiation of Phase 1/2 Clinical Trial of Mirdametin..
2021SpringWorks Therapeutics, Inc. Announces Initiation of Phase 1/2 Clinical Trial of Mird..
2021SpringWorks Therapeutics Announces Presentation of Updated Interim Data from the Phase ..
2021SpringWorks Therapeutics, Inc. Announces Presentation of Updated Interim Data from the ..
2021TRANSCRIPT : SpringWorks Therapeutics, Inc. Presents at Goldman Sachs 42nd Annual Global H..
2021SPRINGWORKS THERAPEUTICS : Seagen Working Together to Study Multiple Myeloma Combination T..
2021SpringWorks Therapeutics Announces Clinical Collaboration with Seagen to Evaluate Nirog..
2021SPRINGWORKS THERAPEUTICS : to Present at the Goldman Sachs 42nd Annual Global Healthcare C..
2021SPRINGWORKS THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form..
1  2  3  4Suiv.
Prochain événement sur SPRINGWORKS THERAPEUTICS, INC.